MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
DexCom DIO Ratio 2011-2026 | DXCM
Annual DIO Ratio DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115 | 126 | 119 | 118 | 141 | 100 | 80.3 | 70.2 | 72.9 | 85 | 104 | 70.4 | 54.8 | 50.7 | 73.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 141 | 50.7 | 92 |
Quarterly DIO Ratio DexCom
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108 | 110 | - | 132 | 140 | 146 | - | 119 | 111 | 110 | - | 51.5 | 63.3 | 138 | - | 150 | 156 | 149 | - | 133 | 128 | 109 | - | 73.2 | 84.2 | 77.8 | - | 65.8 | 72.6 | 80.7 | - | - | - | - | - | - | - | - | - | 105 | 118 | 88.8 | - | 67 | 77.2 | 65.9 | - | 53.7 | 59.1 | 57.1 | - | 45.9 | 55.4 | 66.5 | - | 73.9 | 78.1 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 156 | 45.9 | 95.2 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
97.1 | $ 118.25 | -1.27 % | $ 35.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 22.5 | 9.44 % | $ 242 M |  China |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 22.42 | 27.6 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.46 | 2.82 % | $ 1.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 24.56 | -0.24 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 176.94 | -2.0 % | $ 8.77 B | USA |
 |
Danaher Corporation
DHR
|
87.6 | $ 193.78 | -2.18 % | $ 138 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 132.72 | 0.35 % | $ 21.1 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.13 | -0.25 % | $ 488 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 28.63 | -1.58 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
82.1 | $ 85.7 | 0.99 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
147 | $ 2.2 | 4.27 % | $ 5.05 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 115.58 | -0.79 % | $ 9.53 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 266.36 | -0.14 % | $ 22.2 B | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 83.92 | -0.02 % | $ 5.66 B | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 5.0 | -3.66 % | $ 463 M | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.16 | -5.99 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 9.24 | -1.91 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 191.46 | 0.02 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
405 | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Natera
NTRA
|
25.8 | $ 196.11 | -5.35 % | $ 19.3 B | USA |
 |
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | USA |